A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients

PURPOSE: Combination therapy with aprepitant, serotonin receptor antagonist, and steroids improves the complete response rate of both acute and delayed chemotherapy-induced nausea and vomiting (CINV). However, it is not known whether ramosetron is suitable for administration in combination with apre...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jang, Geundoo, Song, Hun Ho, Park, Keon Uk, Kim, Hyeong Su, Choi, Dae Ro, Kwon, Jung Hye, Kim, Ho Young, Han, Boram, Kim, Jung Han, Jung, Joo Young, Kim, Hyo Jung, Zang, Dae Young
Format: Artigo
Langue:Inglês
Publié: Korean Cancer Association 2013
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804728/
https://ncbi.nlm.nih.gov/pubmed/24155675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.3.172
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires